Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lars Molin is active.

Publication


Featured researches published by Lars Molin.


Chemotherapy | 1971

Rifampicin Compared with Penicillin in the Treatment of Gonorrhea

Anna-Stina Malmborg; Lars Molin; Bertil Nyström

Uncomplicated acute gonorrhea in 200 cases, 100 of each sex, was treated with a single oral dose of 900 mg rifampicin. The failure rate was 12.5%. The treatment was compared with 1.0 MU of benzyl peni


Chemotherapy | 1973

A Comparison between Pivampicillin, Ampicillin and Penicillin G in the Treatment of Acute Uncomplicated Gonorrhoea

Anna-Stina Malmborg; Lars Molin; Bertil Nyström

In the treatment of uncomplicated gonorrhoea pivampicillin, a recently introduced ampicillin derivative with improved oral absorption, has been compared with oral ampicillin and parenteral penicillin


Chemotherapy | 1970

A Comparison between Cephaloridine and Penicillin in the Treatment of Gonorrhoea

Lars Molin; Bertil Nyström

Uncomplicated acute gonorrhoea in 200 cases, 100 of each sex, was treated with a single intra-muscular injection of 2 g of cephaloridine. The failure rate was 10.5 %. This treatment was compared with


Scandinavian journal of social medicine | 1973

Socio-medical aspects on previously hospitalized psoriatics in a metropolitan area.

Lars Molin

Socio-medical circumstances have been studied in previously hospitalized psoriatics living in a metropolitan area. The patterns seen in male and female psoriatics differed. The males were less often gainfully employed, belonged to a lower social class, and had lower incomes than their contrasts. The differences were mostly small, however. The females, on the other hand, were more often gainfully employed, belonged to a higher social class, and had higher incomes than their contrasts. The differences were relatively large and were of statistical significance. In the material studied there was also a marked difference according to sex as regards the severity of psoriasis. The severity of the course of the disease was more severe in the males than in the females. The subjective complaints, however, were assessed almost equal in males and females. The social variables studied could not be convincingly related to the severity of psoriasis or to the subjective assessment of complaints due to the skin disease. Factors other than psoriasis per se were considered more significant, such as primarily varying ability amongst psoriatics to utilize the available medical facilities. Apart from psoriasis itself, the greater morbidity in the psoriatics as compared with their contrasts indicated that psoriatics were more likely to seek hospital treatment for psoriasis if they also had other diseases.


Mycoses | 2009

On the immunosuppresive effect of griseofulvin.

Lars Molin

In 20 males with superficial dermatophytic infections 15 were given griseofulvin during 6 months (1 gram pro die) and 5, as controls, only topical treatment. Delayed hypersensitivity was investigated by means of tuberculin (old tuberkulin) and trichophytin tests before and during the treatment. No reduction of the reactions were noted, thus indicating that the suppressive effect of griseofulvin is weak and seems to be negligible at least during treatment periods not exceeding half a year.


Archives of Dermatology | 1976

Clofazimine: A New Agent for the Treatment of Pyoderma Gangrenosum

Gerd Michaëlsson; Lars Molin; Sven Öhman; Lennart Gip; Börje Lindström; Marcus Skogh; Ingrid Trolin


Mycoses | 2009

On the inhibitory activity of human prostatic fluid on Candida albicans.

Lennart Gip; Lars Molin


Archives of Dermatology | 1982

Topical Mechlorethamine Therapy for Mycosis Fungoides: Proposed Schedule to Overcome Drug Resistance

Gunnar Volden; Lars Molin; Kristian Thomsen


Chemotherapy | 1971

The Ertl-Karger Table System

Meir Kende; J. P. Glynn; D.M. Goldenberg; R.L. Lipman; R.H. McDonald; R.H. Connamacher; A.P. Sharpio; C. Prakash; B.C. Bansal; R.R. Gupta; G. Giunchi; F. de Rosa; F. Fabiani; Anna-Stina Malmborg; Lars Molin; Bertil Nyström; R.C. Misra; D.D. Kulpati; Saroj Bala; K. Prakash; S.K. Gupta; H.K. Chuttani


Chemotherapy | 1970

Contents, Vol. 15, 1970

D.E. Schwartz; J. Rieder; F. Cambieri; A. Gambini; E. Lodola; J.T. Smith; J.M.T. Hamilton-Miller; E. Yourassowsky; R. Monsieur; Lars Molin; Bertil Nyström

Collaboration


Dive into the Lars Molin's collaboration.

Top Co-Authors

Avatar

Bertil Nyström

Karolinska University Hospital

View shared research outputs
Top Co-Authors

Avatar

Anna-Stina Malmborg

Karolinska University Hospital

View shared research outputs
Top Co-Authors

Avatar

Lennart Gip

Karolinska University Hospital

View shared research outputs
Top Co-Authors

Avatar

Kristian Thomsen

Odense University Hospital

View shared research outputs
Top Co-Authors

Avatar

J. P. Glynn

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Meir Kende

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

D.D. Kulpati

Maulana Azad Medical College

View shared research outputs
Top Co-Authors

Avatar

H.K. Chuttani

Maulana Azad Medical College

View shared research outputs
Top Co-Authors

Avatar

K. Prakash

Maulana Azad Medical College

View shared research outputs
Top Co-Authors

Avatar

R.C. Misra

Maulana Azad Medical College

View shared research outputs
Researchain Logo
Decentralizing Knowledge